BioImagene

BioImagene, Inc. is a company that provides digital pathology solutions for clinical diagnostics and drug discovery applications. The company develops and distributes integrated hardware and software systems for acquiring, viewing, sharing, managing, archiving, and analyzing tissue images in pathology laboratories. It offers IHC algorithms such as HER2, ER/PR, and p53 for breast cancer; Ki67 for breast cancer, brain cancer, and prostate cancer; CD138 for multiple myeloma; CD3/CD20 for lymphoma; iSlide input device, which allows pathologists to manipulate digital slide images using a microscope interface; and the iScan Coreo Au digital slide scanner, supporting digital pathology applications like image analysis, telepathology, remote microscopy, and education.